Q&A: Lucian Leape Wants Tougher Patient Safety Regs
Mention the name Lucian Leape, and many providers will promptly think of the Harvard physician who alarmed the country with stunning breadth and scope of avoidable harm taking place in America's hospitals.
He's called the "father" of the modern safety movement, and there's even a Boston institute that carries his name.
A former pediatric surgeon, Leape helped write the Institute of Medicine's two seminal reports, "To Err Is Human" (PDF)in 1999 and "Crossing the Quality Chasm" in 2001, and a decade earlier, authored two research papers in the New England Journal of Medicine revealing that 4% of hospitalized patients in New York suffered adverse events and more than a quarter of those were due to medical negligence.
The Harvard School of Public Health professor again made news at a recent Association of Health Care Journalists conference in Boston when he called for the creation of a special regulatory agency to compel safer hospital practices, using what he referred to as "brute force."
What's been tried through encouraging voluntary efforts, or paying hospitals incentives, or requiring public reporting to improve safety —while somewhat successful— is just taking too darn long, he believes.
"Voluntary is what we've been trying…and it's picking up. There's much more awareness of patient safety; we'll get there, but it may be a long time," he says. "And the accountable care organization movement is dramatically changing the way we pay for healthcare, and that may indeed lead to more collaborative teamwork. Public reporting is another incentive—I call it shaming—but nonetheless it does produce some results."
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening